Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19

Christophe Guervilly, Stephane Burtey, Florence Sabatier, Raphaël Cauchois, Guillaume Lano, Evelyne Abdili, Florence Daviet, Laurent Arnaud, Philippe Brunet, Sami Hraiech, Noémie Jourde-Chiche, Marie Koubi, Romaric Lacroix, Léa Pietri, Yaël Berda, Thomas Robert, Clara Degioanni, Mélanie Velier, Laurent Papazian, Gilles KaplanskiFrançoise DIgnat-George

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Abstract

Beside the commonly described pulmonary expression of the coronavirus disease 2019 (COVID-19), major vascular events have been reported. The objective of this study was to investigate whether increased levels of circulating endothelial cells (CECs) might be associated with severe forms of COVID-19. Ninety-nine patients with COVID-19 were enrolled in this retrospective study. Patients in the intensive care units (ICU) had significantly higher CEC counts than non-ICU patients and the extent of endothelial injury was correlated with putative markers of disease severity and inflammatory cytokines. Together, these data provide in vivo evidence that endothelial injury is a key feature of COVID-19.

Original languageEnglish
Pages (from-to)1789-1793
Number of pages5
JournalJournal of Infectious Diseases
Volume222
Issue number11
DOIs
StatePublished - 1 Dec 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020 The Author(s) 2020.

Keywords

  • COVID-19
  • circulating endothelial cells
  • endothelial injury

Fingerprint

Dive into the research topics of 'Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19'. Together they form a unique fingerprint.

Cite this